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Poly(acrylamide-co-acrylic acid) hydrogels, poly(AAm-co-AAc), were synthesized
by free radical polymerization in solution using N,N’-methylenebisacrylamide
(MBAAm) as the crosslinker. The structural parameters and the swelling behavior of the
synthesized hydrogels were investigated for varying nominal crosslinking ratio and com-
position of the hydrogels. The use of hydrogels for drug release was investigated with
gentamicin sulfate (GS) as the model drug. The drug release from hydrogels was investi-
gated as a function of hydrogel composition, nominal crosslinking ratio (X) and drug
loading. The observed drug release data was fitted to a power law model and the power
law exponent (n) suggested that the drug release mechanism from these hydrogels was
sensitive to hydrogel composition and was swelling-controlled for low concentrations of
AAc and showed Fickian diffusion for high concentrations of AAc in the hydrogels.
Thermogravimetric analysis (TGA) and differential scanning calorimetry (DSC) studies
were performed on control hydrogel samples and drug loaded hydrogels to understand
the chemical interactions between the drug and the polymer. Specific drug interactions
were observed in these hydrogels.
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Introduction
Hydrogels are three-dimensional crosslinked
polymeric structures which are able to absorb and
retain a large amount of water while remaining in-
soluble in aqueous solutions.1 A wide range of hy-
drophilic polymers have been examined as potential
candidates for use in pharmaceutical and medical
field as implants, controlled drug release devices,
enzyme immobilization, as artificial skin, contact
lenses and other uses,2–5 due to characteristic prop-
erties such as biocompatibility, swellability in wa-
ter, high water content and rubbery nature which is
similar to natural tissue.1–6 Special attention has
been directed in recent years towards hydrogels that
display a change in their dynamic and equilibrium
swelling properties in response to external stimuli.
It is known that the swelling behavior of any poly-
mer network depends upon the nature of the poly-
mer, the polymer-solvent compatibility and the de-
gree of crosslinking. Depending upon the polymer,
these hydrogels can undergo significant volume
changes in response to slight changes in environ-
ment which can involve pH, temperature, ionic
strength, buffer composition etc.7–10 In case of an-
ionic polymeric networks, ionization takes place as
the pH of the external medium rises above the pKa
of the ionizable moiety.11 The polymeric network
becomes more hydrophilic as the degree of ioniza-
tion increases and the drug release is accomplished
as the polymer swells. Polyacrylamide hydrogels,
poly(AAm), can absorb relatively high amounts of
water; however their swelling capacity is not very
sensitive to pH or electrolytes.12
Hydrogels of copolymers of acrylic acid (AAc)
with acrylamide (AAm) and its derivatives, have
been reported with adjustable swelling kinetics with
applications for insulin release,13 to improve
osteoblast adhesion14 and showing special proper-
ties such as super-absorbent hydrogels.11,15 Re-
cently, the structural parameters and dynamic swell-
ing behavior of poly(AAm-co-AAc) hydrogels have
been investigated as a function of AAc concentra-
tion in hydrogels and crosslink density at different
pH conditions. The results indicate the diffusion
mechanism to be non-Fickian.16 Owing to the exis-
tence of hydrophilic –COOH and –NH2 groups, the
swelling behavior of these hydrogels is highly de-
pendent on the pH of the surrounding medium. The
water content of hydrogels at equilibrium swelling
condition is one of the basic properties that makes
them useful in drug delivery applications, because
hydrogels with high water content are generally
considered to be more advantageous as they offer
A. THAKUR et al., Hydrogels of Poly(acrylamide-co-acrylic acid): In-vitro Study on …, Chem. Biochem. Eng. Q. 25 (4) 471–482 (2011) 471
*Corresponding author: e-mail: anupamat@pu.ac.in;
Tel.: +91-0172-2534930; Fax: +91-0172-2779173
Original scientific paper
Received: August 30, 2011
Accepted: January 3, 2012
increased permeability and biocompatibility. The
development of a drug delivery system requires
the control of water content within the polymeric
structure, hydrogels based on poly(AAm) and
poly(AAc) have the capacity to absorb a substantial
amount of water which makes them potential candi-
dates for drug delivering systems.
The present work describes the in-vitro release
studies of gentamicin sulfate as the model drug from
poly(AAm-co-AAc) hydrogels as a drug delivery
system. The hydrogels were prepared by free radical
copolymerization of AAm and AAc with MBAAm
as the bifunctional crosslinking agent and ammo-
nium persulfate (APS) and tetraethylene methylene-
diamine (TEMED) as the redox initiator system.16
Poly(AAm-co-AAc) hydrogels were prepared by
changing the initial mole ratio of AAm to AAc and
MBAAm concentration. The use of hydrogels for
drug release was investigated with gentamicin sul-
fate (GS) taken as the model drug. GS, an amino-
glycoside antimicrobial agent having a wide spec-
trum of antimicrobial activity, is still considered a
cornerstone in the treatment of severe infections
caused by gram-negative aerobic bacteria.17
Experimental
Materials
AAc procured from CDH (synthesis grade), was
purified by distillation under reduced pressure. AAm
(CDH, electrophoresis grade) was used as received
without further purification. MBAAm, (Merck, elec-
trophoresis grade) was employed as the crosslinker
for the synthesis of hydrogels without further purifi-
cation. APS, the initiator, and TEMED, the accelera-
tor, were used as a redox initiator pair and were sup-
plied by Merck (A.R.). GS was received as a gift
from M/S Ind-Swift laboratory, Parwanoo, India. It
was used without further purification. Ninhydrin
(Sisco Research Lab, A.R.) and pyridine (Merck,
A.R.) were used as received. Potassium dihydrogen
phosphate, sodium hydroxide and all other reagents
were of analytical grade and double-distilled
deionised water was used throughout.
Hydrogel synthesis
The hydrogels were synthesized using a proce-
dure based on the simultaneous radical polymeriza-
tion and crosslinking of AAm and AAc.16 The poly-
merization mixture was composed of monomers
(AAm and AAc), crosslinker (MBAAm), water as
solvent and redox initiator (APS and TEMED). Ta-
ble 1 lists the sample designation and composition
of the various hydrogels used in this study. The
hydrogels obtained were soft and elastic and uni-
formly cut into samples of short cylindrical shape
with a sharp blade. The samples were first dried
at room temperature and finally under vacuum at
40 °C to constant mass, and stored in desiccators
containing calcium chloride anhydrous (a desiccant
agent, CDH) for further use. The crosslinking ratio
(X), (defined as moles of crosslinking agent/moles
of polymer repeat unit), used in the present study
are given in Table 2.
472 A. THAKUR et al., Hydrogels of Poly(acrylamide-co-acrylic acid): In-vitro Study on …, Chem. Biochem. Eng. Q. 25 (4) 471–482 (2011)
T a b l e 1
– Feed composition and sample designation in the
preparation of poly(AAm-co-AAc) hydrogels










A 20.0000 0.0000 100/0
C 17.9747 2.0253 90/10
D 15.9550 4.0450 80/20
E 13.9412 6.0588 70/30
F 11.9328 8.0672 60/40
G 9.9301 10.0700 50/50
T a b l e 2
– Drug diffusion coefficients calculated with early-time approximation for poly(AAm-co-AAc) hydrogels (eq. 4)
Sample
D · 106 cm2 s–1
(X = 0.0046 mol mol–1)
D · 106 cm2 s–1
(X = 0.0091 mol mol–1)
D · 106 cm2 s–1
(X = 0.0137 mol mol–1)
D · 106 cm2 s–1
(X = 0.0182 mol mol–1)
D · 106 cm2 s–1
(X = 0.0226 mol mol–1)
A 7.12 6.66 5.05 4.32 3.35
C 6.25 5.2 4.61 3.66 3.27
D 4.25 4.05 3.78 3.18 2.42
E 2.90 2.08 1.19 1.04 0.86
F 2.59 3.25 1.31 1.19 0.95
G 1.58 1.95 – – –
Gentamicin sulfate loading in hydrogels
Drug loading was carried out by addition of the
drug during the synthesis of the hydrogels. The drug
loadings (% mg of drug/g polymer) studied in the pre-
sent work are 20 %, 30 %, 40 % and 45 %. Briefly, the
drug was dissolved in the AAm-AAc-MBAAm
monomer solution with continuous stirring under ni-
trogen atmosphere and then crosslinked by the addi-
tion of APS and TEMED under the reaction condi-
tions already discussed in the previous section. The
resulting hydrogels were cut uniformly into cylindri-
cal shape samples, dried first at room temperature and
finally under vacuum at 40 °C to constant mass, and
stored in desiccators containing anhydrous calcium
chloride (a desiccant agent, CDH) for further use.
Drug release experiments
Dry hydrogel samples loaded with GS were
placed in 20 mL buffer solution of pH 7.4 in glass
vials at 37 °C. To follow the release of drug from
hydrogel, the hydrogel samples were removed from
the vials and immersed in fresh 20 mL of buffer
(pre-equilibrated at 37 °C) for continued release at
predetermined time intervals. The amount of drug
released at each time point was determined spectro-
photometrically at 400 nm using a Shimadzu
UV-VIS 2450 spectrophotometer. The amount at
each time point was added to the amount at all pre-
vious points to obtain the cumulative release
amount. The distribution of the drug molecules in
the hydrogel was assumed to be homogeneous.
Control hydrogel samples (samples without genta-
micin) immersed in the buffer solution were treated
as the blank samples during the assay of gentamicin.
The buffer solution of pH 7.4 was prepared18
by mixing 50 mL aliquot of a 0.2 mol L–1 mono-
basic potassium phosphate solution and 39.1 mL of
a 0.2 mol L–1 sodium hydroxide solution and di-
luted to 200 mL with water to form pH 7.4.
Spectrophotometric method of drug estimation
Use of chromatographic, radioimmunoassay and
spectrophotometric methods for assaying amino-
glycosides have been reported in the literature.19
Since gentamicin poorly absorbs ultraviolet and
visible light, indirect spectrophotometric method
for assaying GS is used. The quantitative analysis
of gentamicin was done using 10 g L–1 ninhydrin
aqueous solution as a derivatizing agent.20 The
method is based on the ninhydrin reaction with pri-
mary and secondary amines present in the genta-
micin producing a purple colour. Gentamicin sam-
ples of varying concentrations were prepared in
buffer solution of pH 7.4. Aliquot sample of genta-
micin solution was mixed with freshly prepared
10 g L–1 ninhydrin aqueous solution and pyridine
was added to it. The mixture was heated in a water
bath (Julabo, F20-VC/3) at 70 ± 0.1 °C for 15 min,
which resulted in the formation of purple colouring.
The tubes were then cooled in an ice-water bath.
The UV–visible spectra over the wavelength range
of 300–700 nm was measured (using the mixture
of gentamicin solution, ninhydrin solution and
pyridine) at the appropriate concentrations and
the buffer solution as the blanks. Fig. 1 shows the
spectrophotometric spectrum of gentamicin sample
of 400 g mL–1 prepared in phosphate buffer
of pH 7.4. The scan shows three maxima near
315, 400 and 550 nm. It was observed that the
absorbance values at 400 nm of ninhydrin–pyri-
dine–gentamicin mixtures that were heated for
15 min at 70 °C remained virtually unchanged for
at least 4 h when kept on ice and protected from
light and accordingly absorbance at 400 nm was
measured. However, the spectrophotometric exami-
nation of all the samples was performed within 1 h.
The calibration curve was obtained by linear regres-
sion of absorbance – concentration data. The absor-
bance as a function of concentration followed a lin-
ear model up to a concentration of 120 g mL–1,
given by eq. (1):
y x 001001. (1)
where y represents the absorbance and x represents
the concentration in g mL–1. The equation fits the
calibration data with a regression coefficient (R2) of
0.99928, standard error of estimate of 0.08424 and
residual standard deviation of 0.07059 (eq. 1).
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F i g . 1 – Spectrophotometric curve of gentamicin sulfate
sample of concentration 400 g mL–1 in phos-
phate buffer of pH 7.4
Conditions for gentamicin spectrophotometric method:
2.0 mL gentamicin solution, 2.0 mL ninhydrin
reagent, 0.1 mL pyridine, maintained at 70 °C for
15 min, cooled in ice-water bath, dilution to 25 mL,
absorbance at 400 nm.
Scanning electron microscopy
SEM analysis of hydrogel samples was carried
out using JSM 6100 SEM. Prior to examination,
samples were gold-sputter coated to render them
electrically conductive.
Thermal analysis
Thermal behavior of hydrogels was studied by
thermogravimetric analysis (TGA) and differential
scanning calorimetry (DSC). DSC was performed
using a Mettler Toledo 821e (Switzerland) with a
TS0801RO Sample Robot. The DSC curves were
recorded in the temperature range of 25 to 550 °C
at a heating rate of 10 °C min–1, under N2 atmo-
sphere (50 mL min–1), and evaluated using STARe
Software DB V9.00. Thermal gravimetric analysis
(TGA) was performed using a TGA/SDTA 851e
Mettler Toledo 821e with a TS0801RO Sample Ro-
bot. TGA thermograms were recorded in the tem-
perature range of 25 to 550 °C at a heating rate of
10 °C min–1, under N2 atmosphere (40 mL min
–1),
and evaluated using STARe Software DB V9.00.
Results and discussion
SEM analysis
It is known that the crosslinking ratio and com-
position of hydrogels affects its microstructure which
influences its swelling behavior and hence its drug
release characteristics. The structural parameters
and swelling characteristics of poly(AAm-co-AAc)
hydrogels for some crosslinking ratios have been
reported in our previous work.16 For this, control
hydrogel samples were allowed to equilibrate in the
medium of study. Hydrogels with higher acrylic
acid content presented a more open and porous
channel structure due to electrostatic repulsion of
the ionic charges of its network in basic buffer.
Acrylic acid contains carboxyl groups (–COOH)
and the ionization of these groups above its pKa
(4.7) causes the swelling to increase. In the present
study, the effect of nominal crosslinking ratio on
pore size for hydrogel sample E (70/30) is reported.
Fig. 2 presents scanning electron micrographs of
hydrogels swollen to equilibrium conditions in
buffer solution of pH 7.4 after freeze drying21,22 for
different crosslinking ratios. Freeze-drying was car-
ried out in vacuum at –50 °C for 24 h using Heto
LyoLab 3000 (Denmark) lyophiliser. No crack for-
mation was observed in any of the samples. The
cross-sectional views of the hydrogels present an ir-
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F i g . 2 – Scanning electron micrographs of cross-sections of freeze-dried 70/30 AAm/AAc
hydrogels swollen in buffer of pH 7.4 at various nominal crosslinking ratios X, mol mol–1
(a) X = 0.0046 (ref. 16) (b) X = 0.0091 (ref. 16) (c) X = 0.0137 (d) X = 0.0182
regular surface pattern with macro/micro pores
within the hydrogel. The pore size of hydrogels is
found to decrease with increase in MBAAm con-
centration. Sample E with nominal crosslinking ra-
tio X = 0.0046 presents a surface with a pore size
varying between 60 – 80 m. With the incor-
poration of more crosslinker units in the hydrogel
formulation, hydrogels present a different morphol-
ogy. The hydrogel surface presents pores of size
50 – 60 m at X = 0.0091 and with further increase
in MBAAm concentration, the pore size of hydrogel
at X = 0.0137 is observed to be 7 – 10 m which
further reduces to about 3 – 5 m at nominal cross-
linking ratio of X = 0.0182.
In-vitro drug release
The effect of composition of hydrogels, degree
of crosslinking and drug loading was investigated
on the release of gentamicin sulfate from hydrogels.
(a) Effect of acrylic acid content
Dried drug-loaded hydrogels were used for the
drug release studies. Figs. 3(a-e) show the cumula-
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F i g . 3 – (a) Effect of acrylic acid content on release of gentamicin sulfate in buffer of pH 7.4 at 37 °C at nominal crosslinking ra-
tio X = 0.0046 mol mol–1; (b) Effect of acrylic acid content on release of gentamicin sulfate in buffer of pH 7.4 at 37 °C at nominal
crosslinking ratio X = 0.0091 mol mol–1; (c) Effect of acrylic acid content on release of gentamicin sulfate in buffer of pH 7.4 at
37 °C at nominal crosslinking ratio X = 0.0137 mol mol–1; (d) Effect of acrylic acid content on release of gentamicin sulfate in buffer
of pH 7.4 at 37 °C at nominal crosslinking ratio X = 0.0182 mol mol–1; (e) Effect of acrylic acid content on release of gentamicin sul-
fate in buffer of pH 7.4 at 37 °C at nominal crosslinking ratio X = 0.0226 mol mol–1
tive fractional release of gentamicin sulfate from
poly(AAm-co-AAc) samples in phosphate buffer of
pH 7.4, at 37 ± 0.1 °C. The data was obtained in
triplicate and was reproducible with maximum















where xi represents the experimental value of cumu-
lative fractional drug release (Mt/M) from hydrogel
sample at time t, x is the mean of three readings, n
is the total number of drug release samples taken
during drug release studies for a drug-loaded hydrogel
sample.
Poly(AAm) hydrogel samples demonstrated a
very high burst effect with almost 70 % of the total
drug being released within the first 4 hours. This
burst effect can be attributed to the dissolution or
diffusion of gentamicin sulfate on the surface of the
polymer. As the acrylic acid content increased in
the hydrogels for a given crosslink ratio, the burst
effect was found to decrease substantially. This de-
crease in burst effect with increasing amount of
AAc in hydrogels indicated an acid-base interaction
between the amino group of gentamicin and the
carboxylic groups present in the polymer chains.23
The results indicate that with increasing the amount
of carboxyl group, the interaction between polymer
and drug also increases, which results in a signifi-
cant decrease in the gentamicin sulfate release.
It was observed during drug release studies that
drug-loaded samples showed different swelling and
morphological characteristics. The samples did not
swell appreciably as compared to blank samples of
same composition and crosslinker concentration.
This can be attributed to the strong intermolecular
complexation due to hydrogen bonding between the
carboxylic groups of poly(AAm-co-AAc) and the
highly polar cationic drug; further, due to these
strong intermolecular forces of attraction, hydrogels
did not crack and were observed to be in a swollen
state in phosphate buffer over the course of drug re-
lease studies for high crosslinker ratios. When the
control hydrogel samples were used for swelling
studies at similar higher crosslinker ratios, the sam-
ples were observed to crack after some time, and
hence structural parameters of these hydrogels
could not be investigated.
In order to fit the experimental data of drug re-
lease, the mathematical solution of Fick’s second
law of diffusion proposed by Crank24 (eq. (3)) was
used. This expression is referred to cylindrically
shaped polymer hydrogels, one-dimensional radial




























































where Mt /M is the cumulative fractional drug re-
lease, t is the release time and D is the average dif-
fusion coefficient of the drug in the hydrogel. Eq.
(4) is the early-time approximation equation ob-
tained under the initial and boundary conditions
tested in this work and is valid for the first 60 % of
the data. The early time diffusion coefficients cal-
culated from eq. (4) are reported in Table 2. The
diffusion coefficient values lie in the range of
7.12 · 10–6 cm2 s–1 to 0.95 · 10–6 cm2 s–1 for various
nominal crosslinking ratios and compositions of
hydrogels. It may be mentioned here that diffusion
coefficient of the same order of magnitude has also
been reported by Simovic et al.25 for GS in phos-
phate buffer of pH 7.4.
A simple empirical equation based on a power
law expression, relating cumulative fractional re-
lease of drug to the release time, is one of the most
widely used to interpret release data for swelling
controlled devices. The equation popularly known







where n denotes the type of transport mechanism
for drug diffusion through the polymer and k is a
kinetic constant. For cylindrical geometry, the value
of diffusional exponent n as 0.45 signifies a Fickian
diffusion mechanism, while n  0.89 is Case II dif-
fusion mechanism which indicates zero order re-
lease behavior, while the value of n in the range
0.45 < n < 0.89, indicates that diffusion mechanism
is anomalous or non-Fickian, where both diffusion
and polymer relaxation control the overall rate of
solute transport.7 To determine whether the diffu-
sion rate was controlled by Fickian type diffusion
or swelling of polymer or both, first 60 % of drug
release data was fitted to Ritger and Peppas equa-
tion (eq. 5) and the effect of composition of
hydrogels on the drug mass transport mechanism
was analyzed. The values of the drug diffusion ex-
ponent n, obtained for gentamicin sulfate release in
phosphate buffer for the hydrogels are reported in
Table 3.
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It was observed that an increase in acrylic acid
content of hydrogels yields a change in the drug re-
lease mechanism from anomalous diffusion to
Fickian diffusion. The value of n was found to de-
crease with increase in acrylic acid content of
hydrogels indicating that the relative contribution
of relaxation process of polymer reduces and be-
comes diffusion controlled. This indicates that the
hydrogels serve as a diffusion barrier and the drug
releases mainly by diffusion mechanism supported
by swelling behavior.
(b) Effect of nominal crosslinking ratio
and drug loading on drug release
The influence of nominal crosslinking ratio, X,
on the release of gentamicin sulfate from hydrogels
was investigated. Fig. 3(a-e) shows the cumulative
fractional release from poly(AAm-co-AAc) hydrogels
at different crosslinking ratios and Fig. 4 shows the
cumulative fractional release from sample E with a
drug loading of 30 % at different crosslinking ra-
tios. The diffusion exponent n evaluated from eq.
(5) for drug release from hydrogel samples A and C
(Table 3) was found to be more than 0.45 for
all crosslinking ratios, thereby indicating that
non-Fickian diffusion plays an important role in
drug release from these hydrogels. However, for
hydrogels other than labeled as A and C, diffusion
exponent n depended on crosslinker concentration
to be termed as either Fickian or non-Fickian diffu-
sion. These results indicate that with an increase in
crosslink ratio, there is a decrease in pore size of
the hydrogel structure; it becomes more compact
resulting in a decrease in the amount of drug re-
leased. As a result, the drug release rate from
hydrogels with a high crosslinking ratio decreases
because of the increase in crosslinking density.
Fig. 5 shows the effect of drug loading on
the release pattern as a function of time, in
poly(AAm-co-AAc) hydrogels, (sample E), with a
nominal crosslinking ratio X = 0.0091(mol mol–1).
Hydrogel samples with high drug loadings show
large initial bursts due to more drug clusters con-
nected to the hydrogel surface. At any given time,
the drug release increased with the increase in per-
cent loading of the gentamicin sulfate in hydrogels
in phosphate buffer (pH 7.4) at 37 ± 0.1 oC. The cu-
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T a b l e 3












n k n k n k n k n k
A 0.7582 0.0006 0.7262 0.0008 0.6444 0.0016 0.5892 0.0027 0.5400 0.0039
C 0.6570 0.0011 0.6373 0.0015 0.6028 0.0021 0.5441 0.0034 0.5190 0.0041
D 0.5957 0.0016 0.5444 0.0029 0.5140 0.0038 0.4780 0.0059 0.4428 0.0071
E 0.4856 0.0037 0.4372 0.0059 0.3536 0.0132 0.3395 0.0147 0.3101 0.0196
F 0.3587 0.0152 0.2995 0.0315 0.2420 0.0588 0.2163 0.0692 0.2043 0.0771
G 0.2570 0.0480 0.1769 0.1114 – – – – – –
F i g . 4 – Effect of nominal crosslinking ratio X (mol mol–1)
on gentamicin release from sample E with 30 % drug loading
in buffer of pH 7.4, 37 °C (a) X = 0.0046 (b) X = 0.0091
(c) X = 0.0137 (d) X = 0.0182 (e) X = 0.0226
F i g . 5 – Effect of drug loading (%) on its rate of release
from sample E at X=0.0091 mol mol–1 in buffer of
pH 7.4, 37 °C (a) 20 % (b) 30 % (c) 40 % (d) 45 %
mulative fractional release plots suggest that at
lower concentration of drug, most of the drug mole-
cules remain bounded with carboxylic acid of the
poly(AAc) chain of the hydrogels, whereas, at
higher concentration of drug in hydrogel samples,
the percentage of unbounded drug molecules in-
creases in the polymer networks. Gentamicin sul-
fate is freely soluble in phosphate buffer (pH 7.4).
As a result, the rate of depletion of drug in polymer
at higher concentration is faster than at lower con-
centration of drug. In this process, the hydrogel be-
comes more porous at high drug concentration, and
this increases the diffusion constant of drug in polymer
network.23,26 The early-time diffusion coefficients
(using eq. (4)) for poly(AAm-co-AAc) hydrogels,
(sample E), with a nominal crosslinking ratio
X = 0.0091 (mol mol–1) at various drug loading are
tabulated in Table 4.
Thermal analysis
Thermal behavior of the control hydrogels and
drug-loaded hydrogels was studied by TGA and
DSC to determine the existence of possible interac-
tion between the polymer and drug. Fig. 6(a) shows
the TGA scan of dried sample of poly(AAm)
hydrogel with a crosslinking ratio of 0.0091. It is
observed that the decomposition of poly(AAm)
hydrogel starts at 225 °C and is complete at nearly
460 °C. The total degradation of hydrogel is ob-
served to take place in three stages. In the first stage
a mass loss of about 12 % occurs, and the second
stage beginning at 225 °C, occurs with a mass loss
of about 14 % at 350 °C. The last stage up to
460 °C is characterized by a mass loss of 46 %. The
mass loss occurring in the first stage of temperature
is attributed to the evaporation of water molecules
from the hydrogel. DSC curve of poly(AAm)
hydrogel is shown in Fig. 6(b). It is observed that
an endothermic peak is obtained at nearly 72.41 °C.
Another transition is observed in the temperature
range of 180 – 200 °C as a small kink. A similar ob-
servation has been reported by Iwahara,27 and this
has been analyzed as the glass transition tempera-
ture Tg (transition from a glassy state to a visco-
elastic state) which takes place at a temperature of
about 190.45 °C. The peak at 72.41 °C can be as-
cribed to the loss of water, which could not be re-
moved completely from the hydrogels on drying.
The TGA curve of the dried sample of
poly(AAm-co-AAc) hydrogel (sample E, X = 0.0091
mol mol–1) in Fig. 7(a) shows three degradation
steps. A mass loss of about 10 % occurs in the first
stage. The second stage ranging from 210 – 258 °C
occurs with a mass loss of about 8 %. The third
stage represents the total degradation of the hydrogel,
with a maximum at 370 °C and a mass loss of about
62 %. It is observed that beyond 258 °C, the
hydrogel continues to absorb heat and decomposes
finally at 500 °C. Fig. 7(b) shows the DSC scan of
the same hydrogel. The glass transition is observed
as a small endotherm at approximately 178.35 °C.
The other endothermic peak occurring at 75.59 °C
is due to the evaporation of water from the hydrogel
with an enthalpy change of 163 J g–1.
The thermal behavior of dried sample of
poly(AAc) hydrogel was also studied and is shown
in Fig. 8(a, b) as a TGA and DSC scan. The thermal
degradation of polymer essentially takes place in
two stages. A mass loss of about 1.8 % up to
120 °C occurs before the start of first stage of ther-
mal degradation, which is due to the loss of water
molecules from the hydrogel. The first stage began
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F i g . 6 – (a) TGA curve of poly(AAm) hydrogel at X =
0.0091 mol mol–1; (b) DSC curve of poly(AAm)
hydrogel at X = 0.0091 mol mol–1
T a b l e 4
– Drug diffusion coefficients calculated with
early-time approximation for poly(AAm-co-AAc) hydrogels,
sample E, at X = 0.0091 mol mol–1, for various drug loading (%)














E 1.25 2.08 2.27 3.29
at approximately 120 °C and reached a maximum at
278 °C with a mass loss of about 29 %. The degra-
dation of the polymer is more rapid in the second
stage, which starts at 308 °C with a mass loss of
about 60 % up to 550 °C. From the DSC scan (Fig.
8(b)), it is obvious that a transition occurs over a
relatively narrow temperature range, 65 – 70 °C.
The second transition is visible at approximately
105 °C which is very close to the Tg value of
106 °C reported for poly(AAc) in literature.28 From
the DSC profiles of the above hydrogels (Fig. 6(b),
7(b), 8(b)), it is also observed that water has a higher
evaporation temperature in the poly(AAm-co-AAc)
hydrogel copolymer (75.59 °C) than in poly(AAc)
hydrogel (65 – 70 °C) and poly(AAm) hydrogel
(72.41 °C) suggesting that the interaction between
water molecules and copolymer network are more
numerous than in homopolymer hydrogels.
Both poly(AAm) and poly(AAc) hydrogel are
glassy polymers as their glass transition tem-
peratures are well above the room temperature.
The compatibility between two glassy polymers in
solid state can be assessed by, whether the glass
transition temperature Tg obeys Fox equation. Tg of
poly(AAm) and poly(AAc) was determined to be
190.45 °C and 105 °C respectively (Fig. 6(b), 8(b)).










where Tg1 and Tg2 are the glass transition tempera-
tures of poly(AAm) and poly(AAc), w1 and w2 are
the mass fractions of poly(AAm) and poly(AAc) re-
spectively. The DSC scan of hydrogel sample E
showed a single Tg transition, approximately at
178.35 °C, which is between that of poly(AAm)
and that of poly(AAc). Using the Fox equation, the
glass transition temperature of copolymer turns out
to be 153.1 °C. The presence of additives like
MBAAm, method of synthesis, molecular mass
and the possible interaction of poly(AAm) with
poly(AAc) are some factors which may be respon-
sible for the observed variance of experimentally
determined Tg values of poly(AAm-co-AAc) hydrogel.
Figs. 9(a, b) show the DSC and TGA curves of
the pure drug gentamicin sulfate (GS). GS is a com-
plex mixture of the sulfates of gentamicin C1 (melt-
ing point (m. pt.) 94 – 100 °C), gentamicin C1a and
gentamicin C2 (m. pt. 107 – 124 °C). Some com-
mercial samples may contain significant quantities
of the minor components gentamicin C2a and genta-
micin C2B. The melting point (m. pt.) of the C com-
plex sulfate is given as 218 – 237 °C.30,31 In the
thermogram, Fig. 9(a), a broad endothermic peak
at 103.83 °C and peaks at 244.77, 252.38 and
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F i g . 7 – (a) TGA curve of poly(AAm-co-AAc) hydrogel,
sample E, at X = 0.0091 mol mol–1; (b) DSC curve
of poly(AAm-co-AAc) hydrogel, sample E, at X =
0.0091 mol mol–1
F i g . 8 – (a) TGA curve of poly(AAc) hydrogel at X = 0.0091
mol mol–1; (b) DSC curve of poly(AAc) hydrogel
at X = 0.0091 mol mol–1
287.43 °C were observed. These peaks seem to cor-
respond to the m. pt. of the components of GS com-
plex. The thermal degradation of the pure drug took
place in three stages as shown in Fig. 9(b). In the
first stage, a mass loss of 11.84 % occurred fol-
lowed by a rapid mass loss in the second and third
stages. A mass loss of 8.65 % occurred in the sec-
ond stage with a peak temperature at 225 °C. The
third stage is characterized by total degradation
with a mass loss of 37.89 % up to 405 °C.
Drug-polymer interaction
To examine the interaction of gentamicin sul-
fate (GS) with the polymer, DSC thermogram of
the pure GS was compared with the thermogram
of poly(AAm) and poly(AAm-co-AAc) polymer
hydrogel loaded with GS. Fig. 10(a) shows the
DSC curve of poly(AAm-co-AAc), (sample E,
X =0.0091 mol mol–1), loaded with GS. It is ob-
served that the characteristic sharp peak at 286.6 °C
which corresponds to the m. pt. of one of the com-
ponents of the gentamicin sulfate complex is miss-
ing in the thermogram, whereas, a sharp endother-
mic peak at 324.53 °C is observed suggesting the
formation of an ion pair between the carboxylic
acid group of the polymer and the amino group of
the GS. As reported in literature, an interaction is
known to occur between drug and polymer if ap-
pearance of new peaks or disappearance of peaks is
observed.32 Moreover, the sharp peaks observed in
the DSC curve of pure drug which occur at 244.77,
252.38 and 287.43 °C corresponding to the m. pt.
of other components of C complex sulfate of genta-
micin are not observed as sharp peaks. Instead, a
broad endothermic peak in the temperature range of
230 – 250 °C is observed suggesting interaction be-
tween the polymer and the drug. Another peak
observed in DSC curve at 390.24 °C seems to be
due to degradation of polymer/drug present in the
polymer. A broad endothermic peak observed at
72.90 °C is probably due to the loss of water mole-
cules from the polymer-drug sample. The TGA
curve (Fig. 10(b)) of the polymer-drug sample
shows three stages of degradation. A mass loss of
11.3 % occurs in the first stage up to about 205 °C.
In the second stage a mass loss of about 22 % oc-
curs, and the third stage starting at about 335 °C
shows the final degradation of the polymer with a
mass loss of 37.51 %, and is complete at 500 °C.
DSC curve of poly(AAm) polymer hydrogel
loaded with GS drug is shown in Fig. 11(a). The
peaks occurring at 244.77 °C and 252.38 °C in the
DSC scan of pure drug (Fig. 9(a)) are found to
shift to 250.13 °C and 260.13 °C in drug-loaded
poly(AAm) polymer hydrogel. The slight shift ob-
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F i g . 9 – (a) DSC curve of the pure drug gentamicin sulfate
(GS); (b) TGA curve of the pure drug gentamicin
sulfate (GS)
F i g . 1 0– (a) DSC curve of drug-loaded poly(AAm-co-AAc)
hydrogel, sample E, at X = 0.0091 mol mol–1;
(b) TGA curve of drug-loaded poly(AAm-co-AAc)
hydrogel, sample E, at X = 0.0091 mol mol–1
served in the drug peaks in poly(AAm)-drug sam-
ple may be due to mixing with the polymer31 and
the possible existence of poly(AAm) in a slightly
hydrolysed state resulting in a weak interaction be-
tween the drug and polymer. However, an endother-
mic peak observed at 322.78 °C may be due to deg-
radation of polymer/drug present in the polymer.
From the above results, it may safely be concluded
that the changes observed in the thermal features of
poly(AAm-co-AAc)-drug sample and the appear-
ance of new peaks clearly support the interaction of
drug with the poly(AAm-co-AAc) hydrogel, and
since no new peaks are observed in poly(AAm)-drug
sample, it also confirms the absence of interaction
between the drug and poly(AAm) hydrogel. This
explains the sudden release of drug from the
poly(AAm) hydrogel whereas a comparatively slow
rate of drug release was observed in the case of
poly(AAm-co-AAc) hydrogel samples, with depen-
dence on hydrogel composition crosslinker ratio.
Conclusions
In this study poly(AAm-co-AAc) hydrogels
were synthesized by radical polymerization in solu-
tion at different crosslinking ratios and loaded with
gentamicin sulfate as the model drug. The results
indicated that release of gentamicin sulfphate from
hydrogels is dependent on the composition of the
hydrogels, crosslinking ratio and concentration of
drug in the polymer. The release pattern followed a
two-step pattern, with an initial burst followed by a
slow and continuous release. The diffusion expo-
nent signifying Fickian diffusion or anomalous dif-
fusion for the drug release curve in phosphate
buffer depends upon the degree of crosslinking and
hydrogel composition, and the conditions could be
optimized for the release of drug from these pH
sensitive hydrogels to be used as drug delivery sys-
tems. Thermal analysis of control hydrogels and
drug-loaded hydrogels indicated the existence of
strong interactions between the polymer and the
drug.
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L i s t o f s y m b o l s
a  radius of cylindrical hydrogel sample, cm
D  diffusion coefficient, cm2 s–1
k  kinetic constant
n  diffusion exponent
Mt/M  cumulative fractional drug release from hy-
drogel sample at time t
t  time, s
Tg  glass transition temperature, °C
X  nominal crosslinking ratio, mol mol–1
w  mass fraction, %
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